Literature DB >> 15273292

Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.

Carl S Goodyear1, Gregg J Silverman.   

Abstract

Contributing to host defenses from the adaptive immune system, splenic marginal zone (MZ) B cells, with their preactivated state and special topographical location, serve essential roles as primary defenders from blood-borne microbes. From studies designed to define the immunologic impact of protein A of Staphylococcus aureus (SpA), a virulence factor with targeted B cell antigen receptor-binding properties, we found that within minutes of in vivo exposure, SpA became surface associated with B lymphocytes and induced trafficking. Within several hours, MZ were completely effaced of affected B cells. This was rapidly followed by massive B cell apoptosis, with accelerated preferential deletion of targeted MZ B cells and impaired responsiveness to T independent immunogens. Subsequently, the temporal recovery of MZ B cells was significantly delayed compared to peripheral follicular B cells (B-2 cells). These studies elucidate the cellular program induced by a natural toxin that is shown to be highly efficient at depleting innate-like B cells important for defense from systemic infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273292      PMCID: PMC509211          DOI: 10.1073/pnas.0404382101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  In vivo VL-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxin.

Authors:  Carl S Goodyear; Masami Narita; Gregg J Silverman
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

2.  In vivo effects of LPS on B lymphocyte subpopulations. Migration of marginal zone-lymphocytes and IgD-blast formation in the mouse spleen.

Authors:  P H Groeneveld; T Erich; G Kraal
Journal:  Immunobiology       Date:  1985-12       Impact factor: 3.144

3.  Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody.

Authors:  G Kraal; M Janse
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

4.  Relation of intra-splenic migration of marginal zone B cells to antigen localization on follicular dendritic cells.

Authors:  D Gray; D S Kumararatne; J Lortan; M Khan; I C MacLennan
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

5.  Targeted insertion of a variable region gene into the immunoglobulin heavy chain locus.

Authors:  S Taki; M Meiering; K Rajewsky
Journal:  Science       Date:  1993-11-19       Impact factor: 47.728

6.  Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens.

Authors:  Carola G Vinuesa; Daniel M Y Sze; Matthew C Cook; Kai-Michael Toellner; Gerry G B Klaus; Jennifer Ball; Ian C M MacLennan
Journal:  Eur J Immunol       Date:  2003-02       Impact factor: 5.532

7.  Migrant mu+ delta+ and static mu+ delta- B lymphocyte subsets.

Authors:  D Gray; I C MacLennan; H Bazin; M Khan
Journal:  Eur J Immunol       Date:  1982-07       Impact factor: 5.532

8.  Influence of carriers on the development and localization of anti-2,4,6-trinitrophenyl (TNP) antibody-forming cells in the murine spleen. II. Suppressed antibody response to TNP-Ficoll after elimination of marginal zone cells.

Authors:  E Claassen; N Kors; N Van Rooijen
Journal:  Eur J Immunol       Date:  1986-05       Impact factor: 5.532

9.  Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae.

Authors:  D E Briles; C Forman; S Hudak; J L Claflin
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone.

Authors:  Mikael C I Karlsson; Rodolphe Guinamard; Silvia Bolland; Marko Sankala; Ralph M Steinman; Jeffrey V Ravetch
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

View more
  39 in total

1.  Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice.

Authors:  Hans D Brightbill; Surinder Jeet; Zhonghua Lin; Donghong Yan; Meijuan Zhou; Martha Tan; Allen Nguyen; Sherry Yeh; Donnie Delarosa; Steven R Leong; Terence Wong; Yvonne Chen; Mark Ultsch; Elizabeth Luis; Sree Ranjani Ramani; Janet Jackman; Lino Gonzalez; Mark S Dennis; Anan Chuntharapai; Laura DeForge; Y Gloria Meng; Min Xu; Charles Eigenbrot; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Lawren C Wu
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

Review 2.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

Review 3.  Novel targeted immunotherapy approaches for staphylococcal infection.

Authors:  Michael Otto
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

Review 4.  Staphylococcal manipulation of host immune responses.

Authors:  Vilasack Thammavongsa; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

Review 5.  B cell superantigens: a microbe's answer to innate-like B cells and natural antibodies.

Authors:  Carl S Goodyear; Gregg J Silverman
Journal:  Springer Semin Immunopathol       Date:  2005-03

6.  Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses.

Authors:  Hwan Keun Kim; Hye-Young Kim; Olaf Schneewind; Dominique Missiakas
Journal:  FASEB J       Date:  2011-07-13       Impact factor: 5.191

7.  Staphylococcal Protein Secretion and Envelope Assembly.

Authors:  Olaf Schneewind; Dominique M Missiakas
Journal:  Microbiol Spectr       Date:  2019-07

8.  Corruption of human follicular B-lymphocyte trafficking by a B-cell superantigen.

Authors:  Gwenoline Borhis; Muriel Viau; Gamal Badr; Yolande Richard; Moncef Zouali
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

9.  Release of protein A from the cell wall of Staphylococcus aureus.

Authors:  Samuel Becker; Matthew B Frankel; Olaf Schneewind; Dominique Missiakas
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 10.  The Staphylococcus aureus RNome and its commitment to virulence.

Authors:  Brice Felden; François Vandenesch; Philippe Bouloc; Pascale Romby
Journal:  PLoS Pathog       Date:  2011-03-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.